XML 29 R18.htm IDEA: XBRL DOCUMENT
v3.20.1

Stockholders' Equity | 12 Months Ended
--- | ---
Dec. 31, 2019
Equity [Abstract] |
Stockholders' Equity | Note 12. Stockholders’ Equity Authorized Capital Common Stock. Authorized Shares. The Company is authorized to issue 60,000,000 shares of common stock, par value $0.0001 per share, of which (a) 50,000,000 shares shall be common stock, par value $0.0001, (b) 2,500,000 shares shall be Class A common stock, par value $0.0001 per share (the “Class A Common Stock”), and (c) 7,500,000 shares shall be Class B common stock, par value $0.0001 per share (the “Class B Common Stock”). No shares of Class A Common Stock or Class B Common Stock has been issued. Rights and Preferences. Voting Rights. Except as otherwise required by the Nevada Revised Statues or as provided by or pursuant to the provisions of the Company’s articles of incorporation: (i) Each holder of common stock shall be entitled to one (1) vote for each share of common stock held of record by such holder. The holders of shares of common stock shall not have cumulative voting rights. (ii) Each holder of Class A Common Stock shall be entitled to ten (10) votes for each share of Class A Common Stock held of record by such holder. The holders of shares of Class A Common Stock shall not have cumulative voting rights. (iii) The holders of common stock and Class A Common Stock shall vote together as a single class on all matters on which stockholders are generally entitled to vote. (iv) The holders of Class B Common Stock shall not be entitled to vote on any matter, except that the holders of Class B Common Stock shall be entitled to vote separately as a class with respect to amendments to the Articles of Incorporation that increase or decrease the aggregate number of authorized shares of such class, increase or decrease the par value of the shares of such class, or alter or change the powers, preferences, or special rights of the shares of such class so as to affect them adversely. Preferred Stock Authorized Shares. The Company is authorized to issue 2,500,000 shares of preferred stock, par value $0.0001 per share (the “Preferred Stock”). Rights and Preferences. The Board of Directors is authorized at any time, and from time to time, to provide for the issuance of shares of Preferred Stock in one or more series, and to determine the designations, preferences, limitations and relative or other rights of the Preferred Stock or any series thereof. Stock Repurchase On October 25, 2016 the Company’s Board of Directors authorized the repurchase of up to $1 million of its common stock under Rule 10b-18 promulgated under the Securities Exchange Act of 1934, as amended. Purchases made pursuant to this authorization will be made in the open market, in privately negotiated transactions, or pursuant to any trading plan that may be adopted in accordance with the Rule 10b-18. The timing, manner, price and amount of any repurchases will be determined by the Company in its discretion and will be subject to economic and market conditions, stock price, applicable legal requirements and other factors. On January 9, 2019, VirTra’s Board of Directors authorized an additional $1 million be allocated for the repurchase of VirTra’s stock under the existing 10b-18 plan. Treasury Stock During the year ended December 31, 2019, the Company purchased 82,689 treasury shares at an average cost of $3.85 per share. At December 31, 2019, all treasury shares outstanding had been cancelled and returned to shares authorized. At December 31, 2018, the Company held 10,707 treasury shares at an average cost of $3.48 per share.
|  | Year Ended December 31, |
|  | 2019 |  |  | 2018 |
Period: |  | Total Number of Shares Repurchased |  |  | Average Price Paid per Share |  |  | Total Number of Shares Repurchased |  |  | Average Price Paid per Share |
Repurchased Shares - January-March |  |  | 68,239 |  |  | $ | 3.82 |  |  |  | - |  |  | $ | - |
Repurchased Shares - April-June |  |  | 14,450 |  |  | $ | 3.97 |  |  |  | - |  |  | $ | - |
Repurchased Shares - July-September |  |  | - |  |  | $ | - |  |  |  | - |  |  | $ | - |
Repurchased Shares - October-December |  |  | - |  |  | $ | - |  |  |  | 98,063 |  |  | $ | 3.89 |
Total |  |  | 82,689 |  |  | $ | 3.85 |  |  |  | 98,063 |  |  | $ | 3.89 |
Repurchased Shares Status |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Repurchased Shares Cancelled |  |  | 82,689 |  |  |  |  |  |  |  | 87,356 |  |  |  |  |
Repurchased Shares Held in Treasury |  |  | - |  |  |  |  |  |  |  | 10,707 |  |  |  |  |
Total |  |  | 82,689 |  |  |  |  |  |  |  | 98,063 |  |  |  |  |
Approximate Funds Remaining in Repurchase Plan as of December 31, 2019 |  | $ | 1,188,000 |  |  |  |  |  |  |  |  |  |  |  |  |
Non-qualified Stock Options The Company has periodically issued non-qualified stock options to key employees, officers and directors under a stock option compensation plan approved by the Board of Directors in 2009. Terms of option grants are at the discretion of the Board of Directors and are generally seven years. Upon the exercise of these options, the Company expects to issue new authorized shares of its common stock. The following table summarizes all non-qualified stock options as of:
|  | December 31, 2019 |  |  | December 31, 2018 |
|  | Number of |  |  | Weighted |  |  | Number of |  |  | Weighted |
|  | Stock Options |  |  | Exercise Price |  |  | Stock Options |  |  | Exercise Price |
Options outstanding, beginning of year |  |  | 279,167 |  |  | $ | 2.25 |  |  |  | 531,667 |  |  | $ | 1.85 |
Granted |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
Redeemed |  |  | (34,225 | ) |  |  | 1.13 |  |  |  | (220,523 | ) |  |  | 1.30 |
Exercised |  |  | (10,775 | ) |  |  | 1.06 |  |  |  | (10,700 | ) |  |  | 1.40 |
Expired / terminated |  |  | - |  |  |  | - |  |  |  | (21,277 | ) |  |  | 1.40 |
Options outstanding, end of year |  |  | 234,167 |  |  | $ | 2.47 |  |  |  | 279,167 |  |  | $ | 2.34 |
Options exercisable, end of year |  |  | 234,167 |  |  | $ | 2.47 |  |  |  | 279,167 |  |  | $ | 2.34 |
The Company did not have any non-vested stock options outstanding as of December 31, 2019. The weighted average contractual term for options outstanding and exercisable at December 31, 2019 and 2018 was 7 years. The aggregate intrinsic value of the options outstanding and exercisable at December 31, 2019 and 2018 was $731,112 and $1,745,690, respectively. The total intrinsic value of options exercised during the years ended December 31, 2019 and 2018 was $14,770 and $41,973, respectively. The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying options and the fair value of the Company’s common stock for those stock options that have an exercise price lower than the fair value of the Company’s common stock for those stock options that have an exercise price lower than the fair value of the Company’s common stock. Options with an exercise price above the fair value of the Company’s common stock are considered to have no intrinsic value. For the years ended December 31, 2019 and 2018, the Company received payments related to the exercise of options in the amount of $11,426 and $10,500, respectively. The total fair value of shares vested during the years ended December 31, 2019 and 2018 is $0 and $30,700, respectively. The following table summarizes information about stock options outstanding and exercisable as of December 31, 2019:
Range of Exercise Price |  | Number of Options Outstanding |  |  | Weighted Average Exercise Price |  |  | Number of Options Exercisable |  |  | Weighted Average Exercise Price |
$.80 - $.99 |  |  | 70,000 |  |  | $ | 0.87 |  |  |  | 70,000 |  |  | $ | 0.87 |
$1.00 - $1.99 |  |  | 45,000 |  |  | $ | 1.60 |  |  |  | 45,000 |  |  | $ | 1.60 |
$2.00 - $2.99 |  |  | 42,500 |  |  | $ | 2.48 |  |  |  | 42,500 |  |  | $ | 2.48 |
$3.00 - $3.99 |  |  | 25,000 |  |  | $ | 3.50 |  |  |  | 25,000 |  |  | $ | 3.50 |
$4.00 - $4.99 |  |  | 25,000 |  |  | $ | 4.25 |  |  |  | 25,000 |  |  | $ | 4.25 |
$5.00 - $5.99 |  |  | 26,667 |  |  | $ | 5.50 |  |  |  | 26,667 |  |  | $ | 5.50 |
$.40 - $2.99 |  |  | 234,167 |  |  | $ | 2.47 |  |  |  | 234,167 |  |  | $ | 2.47 |
The following table summarizes information about stock options outstanding and exercisable as of December 31, 2018:
Range of Exercise Price |  | Number of Options Outstanding |  |  | Weighted Average Exercise Price |  |  | Number of Options Exercisable |  |  | Weighted Average Exercise Price |
$.80 - $.99 |  |  | 78,750 |  |  | $ | 0.88 |  |  |  | 78,750 |  |  | $ | 0.88 |
$1.00 - $1.99 |  |  | 81,250 |  |  | $ | 1.40 |  |  |  | 81,250 |  |  | $ | 1.40 |
$2.00 - $2.99 |  |  | 42,500 |  |  | $ | 2.48 |  |  |  | 42,500 |  |  | $ | 2.48 |
$3.00 - $3.99 |  |  | 25,000 |  |  | $ | 3.50 |  |  |  | 25,000 |  |  | $ | 3.50 |
$4.00 - $4.99 |  |  | 25,000 |  |  | $ | 4.25 |  |  |  | 25,000 |  |  | $ | 4.25 |
$5.00 - $5.99 |  |  | 26,667 |  |  | $ | 5.50 |  |  |  | 26,667 |  |  | $ | 5.50 |
$.40 - $2.99 |  |  | 279,167 |  |  | $ | 2.25 |  |  |  | 279,167 |  |  | $ | 2.25 |
2017 Equity Incentive Plan On August 23, 2017, our Board approved, subject to stockholder approval at the annual meeting of stockholders on October 6, 2017, the VirTra, Inc. 2017 Equity Incentive Plan (the “Equity Plan”). The Equity Plan is intended to make available incentives that will assist us to attract, retain and motivate employees, including officers, consultants and directors. We may provide these incentives through the grant of stock options, stock appreciation rights, restricted stock, restricted stock units, performance shares and units and other cash-based or stock-based awards. A total of 1,187,500 shares of our common stock was initially authorized and reserved for issuance under the Equity Plan. This reserve automatically increased on January 1, 2019, and each subsequent anniversary through 2027, by an amount equal to the smaller of (a) 3% of the number of shares of common stock issued and outstanding on the immediately preceding December 31, or (b) an amount determined by the Board. Awards may be granted under the Equity Plan to our employees, including officers, directors or consultants or those of any present or future parent or subsidiary corporation or other affiliated entity. All awards will be evidenced by a written agreement between us and the holder of the award and may include any of the following: stock options, stock appreciation rights, restricted stock, restricted stock units, performance shares and performance units and cash-based awards and other stock-based awards. At December 31, 2019 and 2018, there were no options issued under the Equity Plan.

X
- References No definition available. + Details
Name: | us-gaap_EquityAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -URI http://asc.fasb.org/topic&trid=2208762 + Details
Name: | us-gaap_StockholdersEquityNoteDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration